Search Antibody Database

Found 14 matching records:

Displaying record number 828

Download this epitope record as JSON.

MAb ID	LA9 (121-134)
HXB2 Location	gp160(728-745) DNA(8406..8459)	gp160 Epitope Map
Author Location	gp41(735-752 IIIB)
Epitope	DRPEGIEEEGGERDRDRS	Epitope Alignment
Ab Type
Neutralizing
Species (Isotype)	mouse(IgM)
Patient
Immunogen
Keywords

References

Showing 1 of 1 references.

Evans1989 D. J. Evans, J. McKeating, J. M. Meredith, K. L. Burke, K. Katrak, A. John, M. Ferguson, P. D. Minor, R. A. Weiss, and J. W. Almond. An Engineered Poliovirus Chimera Elicits Broadly Reactive HIV-1 Neutralizing Antibodies. Nature, 339:385-388, 1989. PubMed ID: 2542797. Show all entries for this paper.

---

Displaying record number 829

Download this epitope record as JSON.

MAb ID	ED6
HXB2 Location	gp160(728-745) DNA(8406..8459)	gp160 Epitope Map
Author Location	gp41(735-752 IIIB)
Epitope	DRPEGIEEEGGERDRDRS	Epitope Alignment
Ab Type
Neutralizing
Species (Isotype)	mouse(IgM)
Patient
Immunogen
Keywords

References

Showing 1 of 1 references.

Evans1989 D. J. Evans, J. McKeating, J. M. Meredith, K. L. Burke, K. Katrak, A. John, M. Ferguson, P. D. Minor, R. A. Weiss, and J. W. Almond. An Engineered Poliovirus Chimera Elicits Broadly Reactive HIV-1 Neutralizing Antibodies. Nature, 339:385-388, 1989. PubMed ID: 2542797. Show all entries for this paper.

---

Displaying record number 830

Download this epitope record as JSON.

MAb ID	1575
HXB2 Location	gp160(728-745) DNA(8406..8459)	gp160 Epitope Map
Author Location	gp41(735-752 IIIB)
Research Contact	C. Vella, NIBSC, Potters Bar UK
Epitope	DRPEGIEEEGGERDRDRS	Epitope Alignment
Ab Type	C-term
Neutralizing
Species (Isotype)	mouse
Patient
Immunogen	vaccine
Keywords	review

Vaccine Details

Vaccine type	poliovirus
Vaccine strain	B clade IIIB
Vaccine component	gp41

Notes

Showing 6 of 6 notes.

• 1575: Unlike SAR1, a MAb that binds near the 1575 epitope within the Kennedy peptide, 1575 cannot inhibit fusion between HIV-1 infected and target cells. Heap2005a
• 1575: This review summarizes the complex antigenic properties of an external loop in the gp41 tail (Kennedy sequence), highlighting specific MAbs. 1575 is noted to bind to the epitope IEEE and does not neutralize virus. Dimmock2005 (review)
• 1575: Ab binding to IEEE suppresses neutralizing Ab binding to adjacent epitope ERDRD. Cleveland2000b
• 1575: Study shows that MAb 1575 can recognize the IEEE sequence in both gp41, and in the HPG30 region of the p17 protein -- motif is conserved in both regions in different HIV-1 clades. Buratti1997
• 1575: Core epitope: IEEE -- neutralized IIIB, but not RF or MN. Vella1993
• 1575: Neutralizing activity, less broad than 1577. Evans1989

References

Showing 6 of 6 references.

Evans1989 D. J. Evans, J. McKeating, J. M. Meredith, K. L. Burke, K. Katrak, A. John, M. Ferguson, P. D. Minor, R. A. Weiss, and J. W. Almond. An Engineered Poliovirus Chimera Elicits Broadly Reactive HIV-1 Neutralizing Antibodies. Nature, 339:385-388, 1989. PubMed ID: 2542797. Show all entries for this paper.

Vella1993 C. Vella, M. Ferguson, G. Dunn, R. Meloen, H. Langedijk, D. Evans, and P. D. Minor. Characterization and Primary Structure of a Human Immunodeficiency Virus Type 1 (HIV-1) Neutralization Domain as Presented by a Poliovirus Type 1/HIV-1 Chimera. J. Gen. Virol., 7:15-21, 1993. This study elaborated on a set of antibodies first reported in Evans et al., 1989. Not all of the neutralization results are congruent between the studies. The antibodies in this study were raised to a region including the cytoplasmic domain of gp41 inserted into a poliovirus type 1/HIV-1 chimera. PubMed ID: 7506299. Show all entries for this paper.

Buratti1997 E. Buratti, S. G. Tisminetzky, P. D'Agaro, and F. E. Baralle. A neutralizing monoclonal antibody previously mapped exclusively on human immunodeficiency virus type 1 gp41 recognizes an epitope in p17 sharing the core sequence. J. Virol., 71:2457-62, 1997. PubMed ID: 9032383. Show all entries for this paper.

Cleveland2000b S. M. Cleveland, E. Buratti, T. D. Jones, P. North, F. Baralle, L. McLain, T. McInerney, Z. Durrani, and N. J. Dimmock. Immunogenic and antigenic dominance of a nonneutralizing epitope over a highly conserved neutralizing epitope in the gp41 envelope glycoprotein of human immunodeficiency virus type 1: its deletion leads to a strong neutralizing response. Virology, 266:66-78, 2000. PubMed ID: 10612661. Show all entries for this paper.

Dimmock2005 Nigel J. Dimmock. The Complex Antigenicity of a Small External Region of the C-Terminal Tail of the HIV-1 gp41 Envelope Protein: A Lesson in Epitope Analysis. Rev. Med. Virol., 15(6):365-381, Nov-Dec 2005. PubMed ID: 16106492. Show all entries for this paper.

Heap2005a Caroline J. Heap, Steven A. Reading, and Nigel J. Dimmock. An Antibody Specific for the C-Terminal Tail of the gp41 Transmembrane Protein of Human Immunodeficiency Virus Type 1 Mediates Post-Attachment Neutralization, Probably Through Inhibition of Virus-Cell Fusion. J. Gen. Virol., 86(5):1499-1507, May 2005. PubMed ID: 15831963. Show all entries for this paper.

---

Displaying record number 831

Download this epitope record as JSON.

MAb ID	1576
HXB2 Location	gp160(728-745) DNA(8406..8459)	gp160 Epitope Map
Author Location	gp41(735-752 IIIB)
Epitope	DRPEGIEEEGGERDRDRS	Epitope Alignment
Ab Type
Neutralizing
Species (Isotype)	mouse
Patient
Immunogen	vaccine
Keywords

Vaccine Details

Vaccine type	poliovirus
Vaccine strain	B clade IIIB
Vaccine component	gp41

Notes

Showing 1 of 1 note.

• 1576: Not neutralizing. Vella1993

References

Showing 1 of 1 reference.

Vella1993 C. Vella, M. Ferguson, G. Dunn, R. Meloen, H. Langedijk, D. Evans, and P. D. Minor. Characterization and Primary Structure of a Human Immunodeficiency Virus Type 1 (HIV-1) Neutralization Domain as Presented by a Poliovirus Type 1/HIV-1 Chimera. J. Gen. Virol., 7:15-21, 1993. This study elaborated on a set of antibodies first reported in Evans et al., 1989. Not all of the neutralization results are congruent between the studies. The antibodies in this study were raised to a region including the cytoplasmic domain of gp41 inserted into a poliovirus type 1/HIV-1 chimera. PubMed ID: 7506299. Show all entries for this paper.

---

Displaying record number 836

Download this epitope record as JSON.

MAb ID	1578
HXB2 Location	gp160(728-745) DNA(8406..8459)	gp160 Epitope Map
Author Location	gp41(735-752 IIIB)
Epitope	DRPEGIEEEGGERDRDRS	Epitope Alignment
Ab Type
Neutralizing
Species (Isotype)	mouse
Patient
Immunogen	vaccine
Keywords

Vaccine Details

Vaccine type	poliovirus
Vaccine strain	B clade IIIB
Vaccine component	gp41

Notes

Showing 2 of 2 notes.

• 1578: Core epitope: IEEE -- in this study, neutralized IIIB, but not RF or MN. Vella1993
• 1578: No neutralizing activity -- epitope may be formed by regions from both poliovirus and HIV. Evans1989

References

Showing 2 of 2 references.

Evans1989 D. J. Evans, J. McKeating, J. M. Meredith, K. L. Burke, K. Katrak, A. John, M. Ferguson, P. D. Minor, R. A. Weiss, and J. W. Almond. An Engineered Poliovirus Chimera Elicits Broadly Reactive HIV-1 Neutralizing Antibodies. Nature, 339:385-388, 1989. PubMed ID: 2542797. Show all entries for this paper.

Vella1993 C. Vella, M. Ferguson, G. Dunn, R. Meloen, H. Langedijk, D. Evans, and P. D. Minor. Characterization and Primary Structure of a Human Immunodeficiency Virus Type 1 (HIV-1) Neutralization Domain as Presented by a Poliovirus Type 1/HIV-1 Chimera. J. Gen. Virol., 7:15-21, 1993. This study elaborated on a set of antibodies first reported in Evans et al., 1989. Not all of the neutralization results are congruent between the studies. The antibodies in this study were raised to a region including the cytoplasmic domain of gp41 inserted into a poliovirus type 1/HIV-1 chimera. PubMed ID: 7506299. Show all entries for this paper.

---

Displaying record number 837

Download this epitope record as JSON.

MAb ID	1899
HXB2 Location	gp160(728-745) DNA(8406..8459)	gp160 Epitope Map
Author Location	gp41(735-752 IIIB)
Epitope	DRPEGIEEEGGERDRDRS	Epitope Alignment
Ab Type
Neutralizing
Species (Isotype)	mouse
Patient
Immunogen	vaccine
Keywords

Vaccine Details

Vaccine type	poliovirus
Vaccine strain	B clade IIIB
Vaccine component	gp41

Notes

Showing 1 of 1 note.

• 1899: Could neutralize HIV IIIB and HIV RF. Vella1993

References

Showing 1 of 1 reference.

Vella1993 C. Vella, M. Ferguson, G. Dunn, R. Meloen, H. Langedijk, D. Evans, and P. D. Minor. Characterization and Primary Structure of a Human Immunodeficiency Virus Type 1 (HIV-1) Neutralization Domain as Presented by a Poliovirus Type 1/HIV-1 Chimera. J. Gen. Virol., 7:15-21, 1993. This study elaborated on a set of antibodies first reported in Evans et al., 1989. Not all of the neutralization results are congruent between the studies. The antibodies in this study were raised to a region including the cytoplasmic domain of gp41 inserted into a poliovirus type 1/HIV-1 chimera. PubMed ID: 7506299. Show all entries for this paper.

---

Displaying record number 838

Download this epitope record as JSON.

MAb ID	1579
HXB2 Location	gp160(728-745) DNA(8406..8459)	gp160 Epitope Map
Author Location	gp41(735-752 IIIB)
Epitope	DRPEGIEEEGGERDRDRS	Epitope Alignment
Ab Type
Neutralizing
Species (Isotype)	mouse
Patient
Immunogen	vaccine
Keywords

Vaccine Details

Vaccine type	poliovirus
Vaccine strain	B clade IIIB
Vaccine component	gp41

Notes

Showing 1 of 1 note.

• 1579: Core epitope: IEEE -- neutralized IIIB, but not RF or MN. Vella1993

References

Showing 1 of 1 reference.

Vella1993 C. Vella, M. Ferguson, G. Dunn, R. Meloen, H. Langedijk, D. Evans, and P. D. Minor. Characterization and Primary Structure of a Human Immunodeficiency Virus Type 1 (HIV-1) Neutralization Domain as Presented by a Poliovirus Type 1/HIV-1 Chimera. J. Gen. Virol., 7:15-21, 1993. This study elaborated on a set of antibodies first reported in Evans et al., 1989. Not all of the neutralization results are congruent between the studies. The antibodies in this study were raised to a region including the cytoplasmic domain of gp41 inserted into a poliovirus type 1/HIV-1 chimera. PubMed ID: 7506299. Show all entries for this paper.

---

Displaying record number 839

Download this epitope record as JSON.

MAb ID	1583
HXB2 Location	gp160(728-745) DNA(8406..8459)	gp160 Epitope Map
Author Location	gp41(735-752 IIIB)
Epitope	DRPEGIEEEGGERDRDRS	Epitope Alignment
Ab Type
Neutralizing
Species (Isotype)	mouse
Patient
Immunogen	vaccine
Keywords	review

Vaccine Details

Vaccine type	poliovirus
Vaccine strain	B clade IIIB
Vaccine component	gp41

Notes

Showing 5 of 5 notes.

• 1583: Unlike SAR1, a MAb that binds near the 1583 epitope within the Kennedy peptide, 1583 cannot inhibit fusion between HIV-1 infected and target cells. 1583 and 1577 neutralize only in the presence of complement. Heap2005a
• 1583: This review summarizes the complex antigenic properties of an external loop in the gp41 tail (Kennedy sequence), highlighting specific MAbs. 1577 and 1583 bind to the epitope ERDRD and do not neutralize virus. Dimmock2005 (review)
• 1583: Suggested to bind to a cytoplasmic domain, epitope not exposed at the surface of HIV-1 infected cells. Sattentau1995
• 1583: Core epitope: ERDRD -- Could neutralize HIV IIIB but not HIV RF. Vella1993
• 1583: Neutralizing activity, less broad than 1577. Evans1989

References

Showing 5 of 5 references.

Evans1989 D. J. Evans, J. McKeating, J. M. Meredith, K. L. Burke, K. Katrak, A. John, M. Ferguson, P. D. Minor, R. A. Weiss, and J. W. Almond. An Engineered Poliovirus Chimera Elicits Broadly Reactive HIV-1 Neutralizing Antibodies. Nature, 339:385-388, 1989. PubMed ID: 2542797. Show all entries for this paper.

Vella1993 C. Vella, M. Ferguson, G. Dunn, R. Meloen, H. Langedijk, D. Evans, and P. D. Minor. Characterization and Primary Structure of a Human Immunodeficiency Virus Type 1 (HIV-1) Neutralization Domain as Presented by a Poliovirus Type 1/HIV-1 Chimera. J. Gen. Virol., 7:15-21, 1993. This study elaborated on a set of antibodies first reported in Evans et al., 1989. Not all of the neutralization results are congruent between the studies. The antibodies in this study were raised to a region including the cytoplasmic domain of gp41 inserted into a poliovirus type 1/HIV-1 chimera. PubMed ID: 7506299. Show all entries for this paper.

Sattentau1995 Q. J. Sattentau, S. Zolla-Pazner, and P. Poignard. Epitope Exposure on Functional, Oligomeric HIV-1 gp41 Molecules. Virology, 206:713-717, 1995. Most gp41 epitopes are masked when associated with gp120 on the cell surface. Weak binding of anti-gp41 MAbs can be enhanced by treatment with sCD4. MAb 2F5 binds to a membrane proximal epitope which binds in the presence of gp120 without sCD4. PubMed ID: 7530400. Show all entries for this paper.

Dimmock2005 Nigel J. Dimmock. The Complex Antigenicity of a Small External Region of the C-Terminal Tail of the HIV-1 gp41 Envelope Protein: A Lesson in Epitope Analysis. Rev. Med. Virol., 15(6):365-381, Nov-Dec 2005. PubMed ID: 16106492. Show all entries for this paper.

Heap2005a Caroline J. Heap, Steven A. Reading, and Nigel J. Dimmock. An Antibody Specific for the C-Terminal Tail of the gp41 Transmembrane Protein of Human Immunodeficiency Virus Type 1 Mediates Post-Attachment Neutralization, Probably Through Inhibition of Virus-Cell Fusion. J. Gen. Virol., 86(5):1499-1507, May 2005. PubMed ID: 15831963. Show all entries for this paper.

---

Displaying record number 840

Download this epitope record as JSON.

MAb ID	1907
HXB2 Location	gp160(728-745) DNA(8406..8459)	gp160 Epitope Map
Author Location	gp41(735-752 IIIB)
Epitope	DRPEGIEEEGGERDRDRS	Epitope Alignment
Ab Type
Neutralizing
Species (Isotype)	mouse
Patient
Immunogen	vaccine
Keywords

Vaccine Details

Vaccine type	poliovirus
Vaccine strain	B clade IIIB
Vaccine component	gp41

Notes

Showing 1 of 1 note.

• 1907: Could not neutralize HIV IIIB, RF or MN. Vella1993

References

Showing 1 of 1 reference.

Vella1993 C. Vella, M. Ferguson, G. Dunn, R. Meloen, H. Langedijk, D. Evans, and P. D. Minor. Characterization and Primary Structure of a Human Immunodeficiency Virus Type 1 (HIV-1) Neutralization Domain as Presented by a Poliovirus Type 1/HIV-1 Chimera. J. Gen. Virol., 7:15-21, 1993. This study elaborated on a set of antibodies first reported in Evans et al., 1989. Not all of the neutralization results are congruent between the studies. The antibodies in this study were raised to a region including the cytoplasmic domain of gp41 inserted into a poliovirus type 1/HIV-1 chimera. PubMed ID: 7506299. Show all entries for this paper.

---

Displaying record number 841

Download this epitope record as JSON.

MAb ID	1908
HXB2 Location	gp160(728-745) DNA(8406..8459)	gp160 Epitope Map
Author Location	gp41(735-752 IIIB)
Epitope	DRPEGIEEEGGERDRDRS	Epitope Alignment
Ab Type
Neutralizing
Species (Isotype)	mouse
Patient
Immunogen	vaccine
Keywords

Vaccine Details

Vaccine type	poliovirus
Vaccine strain	B clade IIIB
Vaccine component	gp41

Notes

Showing 2 of 2 notes.

• 1908: Cytoplasmic domain, epitope not exposed at the surface of HIV-1 infected cells. Sattentau1995
• 1908: Neutralized IIIB, but not RF or MN. Vella1993

References

Showing 3 of 3 references.

Evans1989 D. J. Evans, J. McKeating, J. M. Meredith, K. L. Burke, K. Katrak, A. John, M. Ferguson, P. D. Minor, R. A. Weiss, and J. W. Almond. An Engineered Poliovirus Chimera Elicits Broadly Reactive HIV-1 Neutralizing Antibodies. Nature, 339:385-388, 1989. PubMed ID: 2542797. Show all entries for this paper.

Vella1993 C. Vella, M. Ferguson, G. Dunn, R. Meloen, H. Langedijk, D. Evans, and P. D. Minor. Characterization and Primary Structure of a Human Immunodeficiency Virus Type 1 (HIV-1) Neutralization Domain as Presented by a Poliovirus Type 1/HIV-1 Chimera. J. Gen. Virol., 7:15-21, 1993. This study elaborated on a set of antibodies first reported in Evans et al., 1989. Not all of the neutralization results are congruent between the studies. The antibodies in this study were raised to a region including the cytoplasmic domain of gp41 inserted into a poliovirus type 1/HIV-1 chimera. PubMed ID: 7506299. Show all entries for this paper.

Sattentau1995 Q. J. Sattentau, S. Zolla-Pazner, and P. Poignard. Epitope Exposure on Functional, Oligomeric HIV-1 gp41 Molecules. Virology, 206:713-717, 1995. Most gp41 epitopes are masked when associated with gp120 on the cell surface. Weak binding of anti-gp41 MAbs can be enhanced by treatment with sCD4. MAb 2F5 binds to a membrane proximal epitope which binds in the presence of gp120 without sCD4. PubMed ID: 7530400. Show all entries for this paper.

---

Displaying record number 842

Download this epitope record as JSON.

MAb ID	1909
HXB2 Location	gp160(728-745) DNA(8406..8459)	gp160 Epitope Map
Author Location	gp41(735-752 IIIB)
Epitope	DRPEGIEEEGGERDRDRS	Epitope Alignment
Ab Type
Neutralizing
Species (Isotype)	mouse
Patient
Immunogen	vaccine
Keywords

Vaccine Details

Vaccine type	poliovirus
Vaccine strain	B clade IIIB
Vaccine component	gp41

Notes

Showing 1 of 1 note.

• 1909: Neutralized HIV IIIB but not HIV RF. Vella1993

References

Showing 1 of 1 reference.

Vella1993 C. Vella, M. Ferguson, G. Dunn, R. Meloen, H. Langedijk, D. Evans, and P. D. Minor. Characterization and Primary Structure of a Human Immunodeficiency Virus Type 1 (HIV-1) Neutralization Domain as Presented by a Poliovirus Type 1/HIV-1 Chimera. J. Gen. Virol., 7:15-21, 1993. This study elaborated on a set of antibodies first reported in Evans et al., 1989. Not all of the neutralization results are congruent between the studies. The antibodies in this study were raised to a region including the cytoplasmic domain of gp41 inserted into a poliovirus type 1/HIV-1 chimera. PubMed ID: 7506299. Show all entries for this paper.

---

Displaying record number 843

Download this epitope record as JSON.

MAb ID	41-1
HXB2 Location	gp160(728-745) DNA(8406..8459)	gp160 Epitope Map
Author Location	gp41(735-752 IIIB)
Epitope	DRPEGIEEEGGERDRDRS	Epitope Alignment
Ab Type
Neutralizing
Species (Isotype)	mouse(IgMκ)
Patient
Immunogen	vaccine
Keywords	antibody generation

Vaccine Details

Vaccine type	peptide
Vaccine strain	B clade IIIB
Vaccine component	gp41

Notes

Showing 2 of 2 notes.

• 41-1: MAb was raised against peptide DRPEGIEEEGGERDRDRS (peptide sequence given in Kennedy1986). Neutralizes HIV-1 but not HIV-2 strains. Dalgleish1988,Kennedy1986 (antibody generation)
• 41-1 database note: This antibody gp41(735-752 IIIB) Dalgleish1988 seems to have been named the same as a different MAb to gp41(584-609) Mani1994.

References

Showing 2 of 2 references.

Isolation Paper
Dalgleish1988 A. G. Dalgleish, T. C. Chanh, R. C. Kennedy, P. Kanda, P. R. Clapham, and R. A. Weiss. Neutralization of Diverse HIV-1 Strains by Monoclonal Antibodies Raised against a gp41 Synthetic Peptide. Virology, 165:209-215, 1988. PubMed ID: 2838959. Show all entries for this paper.

Kennedy1986 R. C. Kennedy, R. D. Henkel, D. Pauletti, J. S. Allan, T. H. Lee, M. Essex, and G. R. Dreesman. Antiserum to a Synthetic Peptide Recognizes the HTLV-III Envelope Glycoprotein. Science, 231(4745):1556-1559, 28 Mar 1986. PubMed ID: 3006246. Show all entries for this paper.

---

Displaying record number 844

Download this epitope record as JSON.

MAb ID	41-2
HXB2 Location	gp160(728-745) DNA(8406..8459)	gp160 Epitope Map
Author Location	gp41(735-752 IIIB)
Epitope	DRPEGIEEEGGERDRDRS	Epitope Alignment
Ab Type
Neutralizing
Species (Isotype)	mouse(IgMκ)
Patient
Immunogen	vaccine
Keywords	antibody generation

Vaccine Details

Vaccine type	peptide
Vaccine strain	B clade IIIB
Vaccine component	gp41

Notes

Showing 1 of 1 note.

• 41-2: MAb was raised against peptide DRPEGIEEEGGERDRDRS (peptide sequence given in Kennedy1986). Neutralizes HIV-1 but not HIV-2 strains. Dalgleish1988,Kennedy1986 (antibody generation)

References

Showing 2 of 2 reference.

Isolation Paper
Dalgleish1988 A. G. Dalgleish, T. C. Chanh, R. C. Kennedy, P. Kanda, P. R. Clapham, and R. A. Weiss. Neutralization of Diverse HIV-1 Strains by Monoclonal Antibodies Raised against a gp41 Synthetic Peptide. Virology, 165:209-215, 1988. PubMed ID: 2838959. Show all entries for this paper.

Kennedy1986 R. C. Kennedy, R. D. Henkel, D. Pauletti, J. S. Allan, T. H. Lee, M. Essex, and G. R. Dreesman. Antiserum to a Synthetic Peptide Recognizes the HTLV-III Envelope Glycoprotein. Science, 231(4745):1556-1559, 28 Mar 1986. PubMed ID: 3006246. Show all entries for this paper.

---

Displaying record number 845

Download this epitope record as JSON.

MAb ID	41-3
HXB2 Location	gp160(728-745) DNA(8406..8459)	gp160 Epitope Map
Author Location	gp41(735-752 IIIB)
Epitope	DRPEGIEEEGGERDRDRS	Epitope Alignment
Ab Type
Neutralizing
Species (Isotype)	mouse(IgMκ)
Patient
Immunogen	vaccine
Keywords

Vaccine Details

Vaccine type	peptide
Vaccine strain	B clade IIIB
Vaccine component	gp41

Notes

Showing 1 of 1 note.

• 41-3: MAb was raised against peptide DRPEGIEEEGGERDRDRS (peptide sequence given in Kennedy1986). Neutralizes HIV-1 but not HIV-2 strains. Dalgleish1988,Kennedy1986

References

Showing 2 of 2 reference.

Isolation Paper
Dalgleish1988 A. G. Dalgleish, T. C. Chanh, R. C. Kennedy, P. Kanda, P. R. Clapham, and R. A. Weiss. Neutralization of Diverse HIV-1 Strains by Monoclonal Antibodies Raised against a gp41 Synthetic Peptide. Virology, 165:209-215, 1988. PubMed ID: 2838959. Show all entries for this paper.

Kennedy1986 R. C. Kennedy, R. D. Henkel, D. Pauletti, J. S. Allan, T. H. Lee, M. Essex, and G. R. Dreesman. Antiserum to a Synthetic Peptide Recognizes the HTLV-III Envelope Glycoprotein. Science, 231(4745):1556-1559, 28 Mar 1986. PubMed ID: 3006246. Show all entries for this paper.

---